Sang Thrombose Vaisseaux
MENUNew market authorisation for aprotinin in Europe and France. Pratiqual consequences for prescribers Volume 31, issue 1, January-February 2019
Author
- DOI : 10.1684/stv.2019.1057
- Page(s) : 7-9
- Published in: 2019
To access the full article text, click here.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License